Hidradenitissuppurativa
(HS) is a chronic, relapsing inflammatory skin disease that disproportionately
affects women, particularly in intertriginous and genital areas. While its
cutaneous manifestations are well recognized, emerging research emphasizes the
need to address its systemic burden, especially in female patients. Hormonal
fluctuations during menstruation, pregnancy, lactation, and menopause often
exacerbate symptoms, demanding tailored therapeutic strategies. Additionally,
HS in women is frequently accompanied by metabolic, endocrine,
gastrointestinal, and psychological comorbidities, contributing to significant
impairments in quality of life, emotional well-being, and sexual health. The
interplay of physical discomfort, psychological distress, and hormonal
influences necessitates a multidisciplinary, patient-centered approach. In
light of limited approved therapies and frequent off-label use, a holistic,
individualized management framework becomes essential for optimizing care in
women with HS.
Source:
Dattolo, A., Torres, M., Frias-Toral, E., Paganelli, A., Zhang, M., Madonna,
S., Mercurio, L., Cucalón, G., Garbarino, F., Albanesi, C., & Scala, E.
(2025). Beyond the skin: endocrine, psychological and nutritional aspects in
women with hidradenitissuppurativa. Journal of Translational Medicine, 23(1). https://doi.org/10.1186/s12967-025-06175-1
Please login to comment on this article